Jump to Navigation
Trends and Sentiments
Comments and Analysis
3 Habits Productive People Find Time for Every Day
Ringling Bros. and Barnum & Bailey Circus to...
Virtu hopes time can heal HFT furore
The Role of Institutional Investors in Open-Market Share...
Are USW And Oil Refiners Preparing For A Prolonged Strike?
More Sex—and 7 Other Benefits for Men who Help Out at Home
From a shotgun shack to a waterfront estate: What $1-...
U.S. Jobless Claims Highest Since May
NewsWatch: Mark Cuban: This tech bubble is ‘far worse’...
What Top Hedge Fund Managers Really Think About Gold
Good News for Vical Cancer Drug Candidate
Vical, Inc. Q4 2009 Earnings Call Transcript
Biotech Deal Activity Takes a Breather
7 Companies in the Race to Find Cures for Cancer
Vical Incorporated Q1 2010 Earnings Call Transcript
Vical Incorporated. Q2 2010 Earnings Call Transcript
Sanofi Failure Opens Door for Aastrom Bio
Bottom Fishing: Any Value in September's Losers?
15 Biotech Stocks With the Lowest Put/Call Ratios
Vical Analyst and Investor Day Transcript
Seven Stocks With CEO Buying in the Past Week
Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript
18 Stocks on the 52 Week Low List Ready to Pop?
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward
Major FDA Approval Could Pave the Way for These 5 Biotechs
Vical: A Biotech Flying Under the Radar
Chinese CEOs: Cook Your Books at Your Own Peril
7 Dirt Cheap Biotech Stocks With Huge Upside
Breakouts: 6 Stocks Showing New Strength
Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript
4 Biotech Stocks with Extremely Bearish Options Sentiment
Personalized Medicine for the Masses
Careful Analysis Reveals Good Probability of Gains for Vical
ECB posed to raise funding for Greek banks as...
Harworth Estates lands £65m bank deal
EUR/GBP: 1.3814 USD/EUR: 1.1032 JPY/USD: 120.059
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions